Search

Your search keyword '"Rouvière, O"' showing total 298 results
Start Over Author "Rouvière, O" Language english
298 results on '"Rouvière, O"'

5. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Author

Horwich, A., Babjuk, M., Bellmunt, J., Bruins, H.M., De Reijke, T.M., De Santis, M., Gillessen, S., James, N., Maclennan, S., Palou, J., Powles, T., Ribal, M.J., Shariat, S.F., Van Der Kwast, T., Xylinas, E., Agarwal, N., Arends, T., Bamias, A., Birtle, A., Black, P.C., Bochner, B.H., Bolla, M., Boormans, J.L., Bossi, A., Briganti, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Compérat, E., Crabb, S., Culine, S., De Bari, B., DeBlok, W., De Visschere, P.J.L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J.L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J.J., Gakis, G., Geavlete, B., Gontero, P., Grubmüller, B., Hafeez, S., Hansel, D.E., Hartmann, A., Hayne, D., Henry, A.M., Hernandez, V., Herr, H., Herrmann, K., Hoskin, P., Huguet, J., Jereczek-Fossa, B.A., Jones, R., Kamat, A.M., Khoo, V., Kiltie, A.E., Krege, S., Ladoire, S., Lara, P.C., Leliveld, A., Linares-Espinós, E., Løgager, V., Lorch, A., Loriot, Y., Meijer, R., Carmen Mir, M., Moschini, M., Mostafid, H., Müller, A.-C., Müller, C.R., N’Dow, J., Necchi, A., Neuzillet, Y., Oddens, J.R., Oldenburg, J., Osanto, S., Oyen, W.J.G., Pacheco-Figueiredo, L., Pappot, H., Patel, M.I., Pieters, B.R., Plass, K., Remzi, M., Retz, M., Richenberg, J., Rink, M., Roghmann, F., Rosenberg, J.E., Rouprêt, M., Rouvière, O., Salembier, C., Salminen, A., Sargos, P., Sengupta, S., Sherif, A., Smeenk, R.J., Smits, A., Stenzl, A., Thalmann, G.N., Tombal, B., Turkbey, B., Vahr Lauridsen, S., Valdagni, R., Van Der Heijden, A.G., Van Poppel, H., Vartolomei, M.D., Veskimäe, E., Vilaseca, A., Vives Rivera, F.A., Wiegel, T., Wiklund, P., Williams, A., Zigeuner, R., and Witjes, J.A.

Published
2019
Full Text
View/download PDF

7. Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI

Author

Lassau, N., Estienne, T., de Vomecourt, P., Azoulay, M., Cagnol, J., Garcia, G., Majer, M., Jehanno, E., Renard-Penna, R., Balleyguier, C., Bidault, F., Caramella, C., Jacques, T., Dubrulle, F., Behr, J., Poussange, N., Bocquet, J., Montagne, S., Cornelis, F., Faruch, M., Bresson, B., Brunelle, S., Jalaguier-Coudray, A., Amoretti, N., Blum, A., Paisant, A., Herreros, V., Rouviere, O., Si-Mohamed, S., Di Marco, L., Hauger, O., Garetier, M., Pigneur, F., Bergère, A., Cyteval, C., Fournier, L., Malhaire, C., Drape, J.-L., Poncelet, E., Bordonne, C., Cauliez, H., Budzik, J.-F., Boisserie, M., Willaume, T., Molière, S., Peyron Faure, N., Caius Giurca, S., Juhan, V., Caramella, T., Perrey, A., Desmots, F., Faivre-Pierre, M., Abitbol, M., Lotte, R., Istrati, D., Guenoun, D., Luciani, A., Zins, M., Meder, J.-F., and Cotten, A.

Published
2019
Full Text
View/download PDF

9. Clinic Versus Ambulatory Blood Pressure in Resistant Hypertension: Impact of Antihypertensive Medication Nonadherence: A Post Hoc Analysis the DENERHTN Study

Author

Hamdidouche, Idir, Gosse, Philippe, Cremer, Antoine, Lorthioir, Aurelien, Delsart, Pascal, Courand, Pierre-Yves, Denolle, Thierry, Halimi, Jean-Michel, Girerd, Xavier, Ormezzano, Olivier, Rossignol, Patrick, Pereira, Helena, Azizi, Michel, Amar, L, Bobrie, G, Monge, M, Pagny, JY, Sapoval, M, Claisse, G, Midulla, M, Mounier-Vehier, C, Dauphin, R, Fauvel, JP, Lantelme, P, Rouvière, O, Grenier, N, Lebras, Y, Trillaud, H, Dourmap, C, Heautot, JF, Larralde, A, Paillard, F, Cluzel, P, Rosenbaum, D, Alison, D, Popovic, B, Zannad, F, Baguet, JP, Thony, F, Bartoli, JM, Vaïsse, B, Drouineau, J, Herpin, D, Sosner, P, Tasu, JP, Velasco, S, Ribstein, J, Kovacsik, H, Bouhanick, B, Chamontin, B, Rousseau, H, Le Jeune, S, Lopez-Sublet, M, Mourad, JJ, Bellmann, L, Esnault, V, Ferrari, E, and Chatellier, G.

Published
2019
Full Text
View/download PDF

26. Utilisation de l'intelligence artificielle pour l'interprétation de l'IRM prostatique : où en sommes-nous ?

Author

Rouvière, O.

Abstract

Bien que l'IRM se soit imposée dans le diagnostic précoce du cancer de prostate, ses performances restent limitées par sa faible spécificité et sa variabilité interlecteur substantielle. Les progrès récents des techniques d'Intelligence Artificielle en imagerie médicale font espérer que l'analyse automatique des IRM de prostate puisse améliorer la fiabilité et la robustesse de la détection des foyers tumoraux. Cependant, malgré une recherche très active, peu d'algorithmes ont pour l'instant montré des résultats robustes sur des cohortes externes, que ce soit en solution indépendante ou en tant que « second lecteur ». Les principaux défis à résoudre avant le développement clinique de ces algorithmes sont la relative petite taille des bases d'apprentissages et la variabilité des paramètres image en fonction des protocoles d'acquisition, des machines et des constructeurs. Although MRI is widely used for prostate cancer early diagnosis, its performance remains limited by its low specificity and substantial inter-reader variability. Recent advances in Artificial Intelligence techniques in medical imaging give hope that automatic analysis of prostate MRI can improve the reliability and robustness of tumor foci detection. However, despite intensive research, few algorithms have so far shown robust results in external cohorts, either as standalone solutions or as second opinion readers. The main challenges to be solved before the clinical development of these algorithms are the relatively small size of the learning databases and the lack of robustness of image parameters across acquisition protocols, scanners and manufacturers. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

29. PT348 - Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: A systematic review

Author

Van Den Broeck, T., Van Den Bergh, R.C.N., Arfi, N., Gross, T., Moris, L., Briers, E., Cumberbatch, M.G.K., De Santis, M., Tilki, D., Fanti, S., Fossati, N., Gillessen Sommer, S., Grummet, J., Henry, A., Lardas, M., Liew, M., Rouvière, O., Pecanka, J., Mason, M., Schoots, I.G., Van der Kwast, T., Van Der Poel, H.G., Wiegel, T., Willemse, P-P.M., Yuan, Y., Lam, T.B., Cornford, P., and Mottet, N.

Published
2019
Full Text
View/download PDF

31. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)

Author

Witjes, J.A. Babjuk, M. Bellmunt, J. Bruins, H.M. De Reijke, T.M. De Santis, M. Gillessen, S. James, N. Maclennan, S. Palou, J. Powles, T. Ribal, M.J. Shariat, S.F. Van Der Kwast, T. Xylinas, E. Agarwal, N. Arends, T. Bamias, A. Birtle, A. Black, P.C. Bochner, B.H. Bolla, M. Boormans, J.L. Bossi, A. Briganti, A. Brummelhuis, I. Burger, M. Castellano, D. Cathomas, R. Chiti, A. Choudhury, A. Compérat, E. Crabb, S. Culine, S. De Bari, B. De Blok, W. De Visschere, P.J.L. Decaestecker, K. Dimitropoulos, K. Dominguez-Escrig, J.L. Fanti, S. Fonteyne, V. Frydenberg, M. Futterer, J.J. Gakis, G. Geavlete, B. Gontero, P. Grubmüller, B. Hafeez, S. Hansel, D.E. Hartmann, A. Hayne, D. Henry, A.M. Hernandez, V. Herr, H. Herrmann, K. Hoskin, P. Huguet, J. Jereczek-Fossa, B.A. Jones, R. Kamat, A.M. Khoo, V. Kiltie, A.E. Krege, S. Ladoire, S. Lara, P.C. Leliveld, A. Linares-Espinós, E. Løgager, V. Lorch, A. Loriot, Y. Meijer, R. Mir, M.C. Moschini, M. Mostafid, H. Müller, A.-C. Müller, C.R. N'Dow, J. Necchi, A. Neuzillet, Y. Oddens, J.R. Oldenburg, J. Osanto, S. Oyen, W.J.G. Pacheco-Figueiredo, L. Pappot, H. Patel, M.I. Pieters, B.R. Plass, K. Remzi, M. Retz, M. Richenberg, J. Rink, M. Roghmann, F. Rosenberg, J.E. Rouprêt, M. Rouvière, O. Salembier, C. Salminen, A. Sargos, P. Sengupta, S. Sherif, A. Smeenk, R.J. Smits, A. Stenzl, A. Thalmann, G.N. Tombal, B. Turkbey, B. Lauridsen, S.V. Valdagni, R. Van Der Heijden, A.G. Van Poppel, H. Vartolomei, M.D. Veskimäe, E. Vilaseca, A. Rivera, F.A.V. Wiegel, T. Wiklund, P. Willemse, P.-P.M. Williams, A. Zigeuner, R. Horwich, A.

Abstract

The authors regret that a co-author was mistakenly missed from the authorship. The following co-author should have been included in the authorship: Peter-Paul M. Willemse Department of Oncological Urology, University Medical Center, Utrecht Cancer Center, Utrecht, The Netherlands © 2019 European Society of Medical Oncology and European Association of Urology

Published
2020

32. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

Author

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Subjects
Consensus, Follow-up, education, Bladder cancer, Diagnosis, Treatment, Delphi
Abstract

Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Objective: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. Design: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts prior to voting during a consensus conference. Setting: Online Delphi survey and consensus conference. Participants: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. Outcome measurements and statistical analysis: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), and 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). Results and limitations: Overall, 116 statements were included in the Delphi survey. Of these statements, 33 (28%) achieved level 1 consensus and 49 (42%) achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease, and the evolving role of checkpoint inhibitor therapy in metastatic disease. Conclusions: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time when further evidence is available to guide our approach. Patient summary: This report summarises findings from an international, multistakeholder project organised by the EAU and ESMO. In this project, a steering committee identified areas of bladder cancer management where there is currently no good-quality evidence to guide treatment decisions. From this, they developed a series of proposed statements, 71 of which achieved consensus by a large group of experts in the field of bladder cancer. It is anticipated that these statements will provide further guidance to health care professionals and could help improve patient outcomes until a time when good-quality evidence is available.

Published
2020

36. Kindey Cortex Segmentation in 2D CT with U-Nets Ensemble Aggregation

Author

Couteaux, Vincent, Si-Mohamed, S., Renard-Penna, R., Nempont, O., Lefevre, T., Popoff, A., Pizaine, Guillaume, Villain, N., Bloch, Isabelle, Behr, J., Bellin, M.-F., Roy, C., Rouvière, O., Montagne, S., Lassau, N., Boussel, L., Image, Modélisation, Analyse, GEométrie, Synthèse (IMAGES), Laboratoire Traitement et Communication de l'Information (LTCI), Institut Mines-Télécom [Paris] (IMT)-Télécom Paris-Institut Mines-Télécom [Paris] (IMT)-Télécom Paris, Département Images, Données, Signal (IDS), and Télécom ParisTech

Subjects
[INFO.INFO-LG]Computer Science [cs]/Machine Learning [cs.LG], [INFO.INFO-IM]Computer Science [cs]/Medical Imaging, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2019

37. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Author

Horwich, A. Babjuk, M. Bellmunt, J. Bruins, H.M. De Reijke, T.M. De Santis, M. Gillessen, S. James, N. Maclennan, S. Palou, J. Powles, T. Ribal, M.J. Shariat, S.F. Van Der Kwast, T. Xylinas, E. Agarwal, N. Arends, T. Bamias, A. Birtle, A. Black, P.C. Bochner, B.H. Bolla, M. Boormans, J.L. Bossi, A. Briganti, A. Brummelhuis, I. Burger, M. Castellano, D. Cathomas, R. Chiti, A. Choudhury, A. Compérat, E. Crabb, S. Culine, S. De Bari, B. DeBlok, W. De Visschere, P.J.L. Decaestecker, K. Dimitropoulos, K. Dominguez-Escrig, J.L. Fanti, S. Fonteyne, V. Frydenberg, M. Futterer, J.J. Gakis, G. Geavlete, B. Gontero, P. Grubmüller, B. Hafeez, S. Hansel, D.E. Hartmann, A. Hayne, D. Henry, A.M. Hernandez, V. Herr, H. Herrmann, K. Hoskin, P. Huguet, J. Jereczek-Fossa, B.A. Jones, R. Kamat, A.M. Khoo, V. Kiltie, A.E. Krege, S. Ladoire, S. Lara, P.C. Leliveld, A. Linares-Espinós, E. Løgager, V. Lorch, A. Loriot, Y. Meijer, R. Carmen Mir, M. Moschini, M. Mostafid, H. Müller, A.-C. Müller, C.R. N'Dow, J. Necchi, A. Neuzillet, Y. Oddens, J.R. Oldenburg, J. Osanto, S. Oyen, W.J.G. Pacheco-Figueiredo, L. Pappot, H. Patel, M.I. Pieters, B.R. Plass, K. Remzi, M. Retz, M. Richenberg, J. Rink, M. Roghmann, F. Rosenberg, J.E. Rouprêt, M. Rouvière, O. Salembier, C. Salminen, A. Sargos, P. Sengupta, S. Sherif, A. Smeenk, R.J. Smits, A. Stenzl, A. Thalmann, G.N. Tombal, B. Turkbey, B. Vahr Lauridsen, S. Valdagni, R. Van Der Heijden, A.G. Van Poppel, H. Vartolomei, M.D. Veskimäe, E. Vilaseca, A. Vives Rivera, F.A. Wiegel, T. Wiklund, P. Williams, A. Zigeuner, R. Witjes, J.A.

Subjects
education
Abstract

Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Objective: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. Design: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. Setting: Online Delphi survey and consensus conference. Participants: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. Outcome measurements and statistical analysis: Statements were ranked by experts according to their level of agreement: 1–3 (disagree), 4–6 (equivocal), 7–9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). Results and limitations: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. Conclusions: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time where further evidence is available to guide our approach. © 2019 European Society for Medical Oncology

Published
2019

38. Mesure des concentrations intracellulaires de phosphate inorganique et d’ATP par Spectroscopie par Résonance Magnétique pendant une séance d’hémodialyse chez l’insuffisant rénal chronique terminal (Etude CIPHEMO)

Author

Chazot, G., Lemoine, S., Kocevar, G., Kalbacher, Elsa, Varennes, Annie, Carlier, M.C., Normand, G., Sappey-Marinier, Dominique, Rouvière, O., Juilard, L., RMN et optique : De la mesure au biomarqueur, Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé (CREATIS), Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Edouard Herriot [CHU - HCL], and Hospices Civils de Lyon (HCL)

Subjects
[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging, ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2018

39. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial

Author

Pereira, Helena, Del Giudice, Costantino, Dourmap, Caroline, Azarine, Arshid, Azizi, Michel, Amar, L., Lorthioir, A., Monge, Matthieu, Pagny, J.‐Y., Claisse, G., Delsart, Pascal, Midulla, M., Mounier‐Vehier, Claire, Courand, Pierre-Yves, Dauphin, R., Fauvel, J., Lantelme, Pierre, Rouvière, O., CREMER, A., Gosse, Philippe, Grenier, N., Lebras, Y., Trillaud, H., Denolle, Thierry, Dourmap‐Collas, C., Heautot, J., Larralde, A., Paillard, F., Cluzel, P., Girerd, Xavier, Rosenbaum, D., Alison, D., Claudon, M., Popovic, B., Rossignol, Patrick, Ormezzano, Olivier, Thony, F., Bartoli, J., Vaisse, Bernard, Drouineau, J., Herpin, Daniel, Sosner, P., Tasu, J., Velasco, S., Ribstein, Jean, Bouhanick, Beatrice, Chamontin, B., Rousseau, H., Le Jeune, S., Lopez‐Sublet, M., Mourad, Jean‐Jacques, Bellmann, L., Esnault, V., Ferrari, Emile, Sapoval, Marc, Bobrie, Guillaume, Chatellier, Gilles, Plouin, P., Zannad, Faiez, Halimi, Jean Michel, Baguet, J., Kovacsik, H., Durand‐Zaleski, I., Beregi, J., Lièvre, M., Persu, A., Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon

Subjects
[SDV]Life Sciences [q-bio], ComputingMilieux_MISCELLANEOUS
Abstract

International audience

Published
2017
Full Text
View/download PDF

42. P0324 - A systematic review on the impact of surgeon and hospital caseload volume on oncological and non-oncological outcomes after radical prostatectomy for non-metastatic prostate cancer

Author

Van Den Broeck, T., Oprea-Lager, D., Moris, L., Kailavasan, M., Briers, E., Cornford, P., De Santis, M., Gandaglia, G., Gillessen Sommer, S., Grummet, J.P., Grivas, N., Lam, T.B., Lardas, M., Liew, M., Mason, M., O’Hanlon, S., Ploussard, G., Rouvière, O., Schoots, I., Tilki, D., Van Den Bergh, R.C.N., Van Der Poel, H., Wiegel, T., Willemse, P., and Mottet, N.

Published
2021
Full Text
View/download PDF

43. P0298 - Evaluation of oncological outcomes and data quality in studies assessing nerve sparing versus non-nerve sparing radical prostatectomy in non-metastatic prostate cancer: A systematic review

Author

Moris, L., Gandaglia, G., Vilaseca, A., Van Den Broeck, T., Briers, E., De Santis, M., Gillessen, S., Grivas, N., Henry, A., Lam, T.B., Lardas, M., Mason, M., Oprea-Lager, D., Ploussard, G., Rouvière, O., Schoots, I.G., Van Der Poel, H., Wiegel, T., Willemse, P-P., Grummet, J.P., Tilke, D., Van Den Bergh, R.C.N., Cornford, P., and Mottet, N.

Published
2021
Full Text
View/download PDF

46. PT010 - Systematic review of quality of life outcomes after primary treatment for clinically localised prostate cancer

Author

Lardas, M., Liew, M., Van Den Bergh, R.C., De Santis, M., Bellmunt, J., Van Den Broeck, T., Cornford, P., Cumberbatch, M.G., Fossati, N., Gross, T., Henry, A.M., Bolla, M., Briers, E., Joniau, S., Lam, T.B., Mason, M.D., Mottet, N., Van Der Poel, H.G., Rouvière, O., Schoots, I.G., Wiegel, T., Willemse, P.P.M., Yuan, C.Y., and Bourke, L.

Published
2018
Full Text
View/download PDF

47. PT008 - What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis

Author

Moldovan, P., Van Den Broeck, T., Sylvester, R., Marconi, L., Bellmunt, J., Van Den Bergh, R.C.N., Bolla, M., Briers, E., Cumberbatch, M.G., Fossati, N., Gross, T., Henry, A.M., Joniau, S., Van Der Kwast, T.H., Matveev, V.B., Van Der Poel, H.G., De Santis, M., Schoots, I.G., Wiegel, T., Yuan, C.Y., Cornford, P., Mottet, N., Lam, T.B., and Rouvière, O.

Published
2018
Full Text
View/download PDF

49. Evaluation of a 3D MR/MR elastic registration method for prostate cancer imaging

Author

Lehaire, J., Lartizien, C., Niaf, E., Baumann, M., Souchon, R., Bratan, F., Rouvière, O., 2 - Images et Modèles, Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé ( CREATIS ), Hospices Civils de Lyon ( HCL ) -Université Jean Monnet [Saint-Étienne] ( UJM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon ( INSA Lyon ), Université de Lyon-Institut National des Sciences Appliquées ( INSA ) -Institut National des Sciences Appliquées ( INSA ) -Hospices Civils de Lyon ( HCL ) -Université Jean Monnet [Saint-Étienne] ( UJM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Institut National des Sciences Appliquées ( INSA ) -Institut National des Sciences Appliquées ( INSA ), Application des ultrasons à la thérapie ( LabTAU ), Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Société KOELIS, entreprise, Department of Urinary and Vascular Radiology, Hospices Civils de Lyon ( HCL ), Images et Modèles, Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé (CREATIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Application des ultrasons à la thérapie (LabTAU), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), and Hospices Civils de Lyon (HCL)

Subjects
[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging, [ SPI.SIGNAL ] Engineering Sciences [physics]/Signal and Image processing, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, [ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/Imaging
Abstract

International audience; Early detection and localization of prostate cancer is crucial for appropriate patient management. Recent studies suggest that computer-assisted diagnosis systems combining different imaging modalities (MR/MR, MR/US) can improve prostate cancer detection1 and open the wayto targeted biopsies and focal therapy2. Such fusion processes are limited by prostate motion and deformation, particularly at the prostate-rectum interface. A non-rigid multimodal image registration process based on shape statistics has been developed to coregister T2-weighted MR and 3D transrectal ultrasound acquisitions3. Based on the good precision achieved4, this method was adapted to coregister T2-weighted, diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) images and evaluated on 28 prostate cancer patients.

Published
2013

50. Renal safety evaluation after Dotarem®-enhanced-MRI compared with non-enhanced-MRI in patients at high risk of developing contrast medium induced nephropathy

Author

Deray, G., Marti Bonmati, L., Rouvière, O., Maes, B., Rollandi, Ga, Hannedouche, T., Vrtovsnik, F., Grenier, N., Billiouw, Jm, Campioni, Paolo, Verstraete, K., Ferreiros, J., Alison, D., Glowacki, F., and Boffa, Jj

Subjects
nephropathy, gadolinium, MR, Contrast agents
Abstract

Purpose Methods and Materials Results Conclusion References Personal Information, Purpose: With the common use of contrast media (CM) in diagnostic and interventional procedures, contrast-induced nephropathy (CIN) has become one of the leading cause of hospital-acquired acute renal injury [1,2]. Although CIN has been well studied for...

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results